887 related articles for article (PubMed ID: 22438081)
1. TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice.
Nunes AF; Amaral JD; Lo AC; Fonseca MB; Viana RJ; Callaerts-Vegh Z; D'Hooge R; Rodrigues CM
Mol Neurobiol; 2012 Jun; 45(3):440-54. PubMed ID: 22438081
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice.
Lo AC; Callaerts-Vegh Z; Nunes AF; Rodrigues CM; D'Hooge R
Neurobiol Dis; 2013 Feb; 50():21-9. PubMed ID: 22974733
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.
Xuan AG; Pan XB; Wei P; Ji WD; Zhang WJ; Liu JH; Hong LP; Chen WL; Long DH
Mol Neurobiol; 2015 Feb; 51(1):300-12. PubMed ID: 24854198
[TBL] [Abstract][Full Text] [Related]
6. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
8. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
[TBL] [Abstract][Full Text] [Related]
9. Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions.
Li X; Uemura K; Hashimoto T; Nasser-Ghodsi N; Arimon M; Lill CM; Palazzolo I; Krainc D; Hyman BT; Berezovska O
Neurobiol Dis; 2013 Feb; 50():127-34. PubMed ID: 23064434
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
[TBL] [Abstract][Full Text] [Related]
11. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
12. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
[TBL] [Abstract][Full Text] [Related]
14. The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model.
Zangerolamo L; Vettorazzi JF; Solon C; Bronczek GA; Engel DF; Kurauti MA; Soares GM; Rodrigues KS; Velloso LA; Boschero AC; Carneiro EM; Barbosa HCL
Mol Cell Endocrinol; 2021 Feb; 521():111116. PubMed ID: 33321116
[TBL] [Abstract][Full Text] [Related]
15. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
[TBL] [Abstract][Full Text] [Related]
16. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
[TBL] [Abstract][Full Text] [Related]
17. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
18. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM
CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738
[TBL] [Abstract][Full Text] [Related]
19. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
